|
Published by: Datamonitor
Published: Aug. 23, 2001 - 82 Pages
Table of Contents
DATAMONITOR HEALTHCARE
CONTACT DETAILS
EXECUTIVE SUMMARY
Scope
Datamonitor insight into the panic disorder market
Key metrics
TABLE OF CONTENTS
EPIDEMIOLOGY
Definition
Diagnostic criteria
Comorbidities
Panic disorder with agoraphobia
Other comorbid conditions
Patient potential
Prevalence rates
Epidemiological conclusion
CLINICAL PRACTICE
Introduction
Diagnosis
Guidelines in existence
Physician diagnosis rate
Treatment
Breakdown of panic disorder in anxiety disorders
First line panic disorder treatment
Overall panic disorder treatment
Influence on panic disorder marketing
The lack of a leading product
The potential for the noradrenergic class
The high level of comorbidity
CURRENT PANIC DISORDER MARKET
Antidepressant use in panic disorder
Paxil
Zoloft
Celexa/Cipramil
Prozac
Serzone
Luvox
Effexor
Remeron
Other antidepressants
Conclusion
Other drugs used in panic disorder
Anxiolytics
Anticonvulsants
The global panic disorder market 2001
THE FUTURE DECODED
Unmet needs in treating panic disorder
The panic disorder R&D pipeline
Paroxetine CR
Fluoxetine
Venlafaxine
Nefazodone
Pregabalin
Pagoclone
SLV308
The panic disorder market 2001-2008
Factors influencing the future panic disorder market
Future drug launches
Panic disorder market forecast to 2008
Panic disorder market forecast 2005
Panic disorder market forecast 2008
APPENDIX
Datamonitor's Central Nervous System Business Unit
Table of tables
Epidemiology
Clinical trials
Websites
R&D research methodology
Introduction
Hypothesis formulation
Hypothesis testing
Data verification and quality control
Physician research questionnaire
Diagnosis
Treatment
Unmet needs
Pricing data
Introduction
Source prices
Ex-manufacturer, wholesaler and retail prices
Data validation and margin calculation
Quality control
Patent expiries
AbstractDatamonitor's Strategic Perspectives 2001: Anxiety Disorders series of eight reports form a comprehensive review of major anxiety and eating disorder markets. Each report utilizes primary research data in the seven leading healthcare markets and investigates the current state of affairs in each market. Furthermore they provide an in-depth analysis of the current pipeline, estimated drug launches and the future direction of each anxiety disorder. Anxiety Disorders covered: Eating Disorders (Anorexia Nervosa and Bulimia Nervosa) Generalized Anxiety DisorderObsessive Compulsive Disorder Panic DisorderPhobias (Specific Phobia and Agoraphobia)Post Traumatic Stress DisorderPremenstrual Dysphoric Disorder Social Anxiety Disorder
Get Full Details About This Report >>
|
